Who owns LEMAITRE VASCULAR INC (LMAT)? Elite investor 13F holders

3 tracked elite investors reported holding LEMAITRE VASCULAR INC as of 2026-06-30, including Renaissance Technologies LLC, D.E. Shaw, Gotham Asset Management. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

3 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Health Care Equipment & Services

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific. The company offers allografts, which are cryopreserved human tissue grafts used in vascular reconstruction, and cardiac repair and reconstruction; embolectomy catheters to remove blood clots from…

Reported holders and securities, including exits (up to 20)

Reported holders and securities, including exits (up to 20)
InvestorSecurityInstrumentReport periodFiledValueQuantityUnitsChangeSource
Renaissance Technologies LLCLEMAITRE VASCULAR INCSHARE2026-06-302026-08-13 00:00:0016265412.00 USD169502.000000SharesaddOriginal filing
D.E. ShawLEMAITRE VASCULAR INCSHARE2026-06-302026-08-14 00:00:003499085.00 USD36464.000000SharesreduceOriginal filing
Tudor InvestmentLEMAITRE VASCULAR INCSHARE2026-06-302026-08-14 00:00:000.00 USD0.000000SharesexitedOriginal filing
Gotham Asset ManagementLEMAITRE VASCULAR INCSHARE2026-06-302026-08-14 00:00:001522501.00 USD15866.000000SharesaddOriginal filing

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

How to read the data · Disclaimer

Read as Markdown